Renerva, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-30.
Renerva, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 30, 2025. The filing reports $325K sold. Its industry group is Other Health Care. It names Lorenzo Soletti (CEO, President, Treasurer, and Secretary), Bryan Brown (Chief Technology Officer), Peter DeComo (Director) (SEC Form D, September 30, 2025).
Is this your company?
Sell to companies like Renerva, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Renerva, Inc.
Free to see. No signup.
More on the people and the money behind Renerva, Inc., from the filings we hold.
Other Health Care raises by companies based in Pennsylvania, filed in September 2025, largest first.
Get an email when Renerva, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Renerva, Inc. raises, hires or launches. No email unless you switch it on.
Watch Renerva, Inc. →Get the full cited report on Renerva, Inc.
What the filing shows about Renerva, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Renerva, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Renerva, Inc.'s address as 2403 Sidney Street, Suite 280, Pittsburgh, PA 15203.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Renerva, Inc. is a registered filer with the SEC (CIK 1748198) and has filed since 2024-06-27. 3 filings are on record, the latest on 2025-09-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Renerva, Inc.'s Form D of 2025-09-30 names Lorenzo Soletti, Bryan Brown, Peter DeComo and 1 more as its officers, directors or promoters.
Its new offerings report $325K sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 871 filings in Other Health Care, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Renerva is an innovative medical device company committed to developing the next generation of surgical solutions to improve healing following nerve injury. Renerva
The title and description the site itself served, answering 200, after redirecting from https://renerva.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director, Promoter.
Lorenzo Soletti is named as Ceo, President, Treasurer, and Secretary on the Form D that Renerva, Inc. filed with the SEC on 30 September 2025, one of 4 people that filing names.
On the filing as: Executive Officer.
Bryan Brown is named as Chief Technology Officer on the Form D that Renerva, Inc. filed with the SEC on 30 September 2025, one of 4 people that filing names.
Peter DeComo is named as Director on the Form D that Renerva, Inc. filed with the SEC on 30 September 2025, one of 4 people that filing names.
William Sekkel is named as Director on the Form D that Renerva, Inc. filed with the SEC on 30 September 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-09-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Renerva, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Renerva, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Renerva, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Renerva, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Renerva, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (renerva.com).
Each opens in a new tab, filled in for Renerva, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Pittsburgh
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/renerva-inc-form-d-25000001